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 HYPERTENSIVE DISORDERS OF PREGNANCY, COMPLICATIONS AND 
OBSTETRIC OUTCOME AT PRINCESS MARINA HOSPITAL, GABORONE, 
BOTSWANA. 
      Nkubito GK, Stray-Pedersen B, Hussain A. 
 ABSTRACT 
OBJECTIVES: To determine the prevalence, maternal complications, foetal outcome and 
characteristics of patients with hypertensive disorders of pregnancy. 
SETTING: Princess Marina Hospital, a tertiary and referral Hospital in Gaborone, 
Botswana. 
MATERIALS AND METHODS:  A retrospective chart review of all hypertensive 
women who delivered at Princess Marina Hospital from December 2002 to April 2003 
was done. 
Information from patients’ records was entered on a compilation sheet which was entered 
in SPSS program and analyzed. Prevalence rates (per 1000 deliveries) were estimated by 
type of hypertension. Demographic characteristics, maternal complications and perinatal 
outcome were also determined. 
RESULTS: Of 1919 deliveries at Princess Marina Hospital during the study period, there 
were 100 cases of hypertensive disorders of pregnancy giving a prevalence of 52.1 per 
1000 deliveries. Twenty one cases had chronic hypertension of which 11 (52%) 
developed superimposed pre-eclampsia while 10(48%) had no proteinuria.  
Of 79 patients with pregnancy induced hypertension, 36 (46%) had hypertension without 
proteinuria, 42(53%) had pre-eclampsia and 1(1%) had eclampsia. 
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Age ranged from 18 to 47 years with a mean age of 29.5 years. Teenagers were 8 cases 
out of 100. Maternal complications were HELLP syndrome (3 cases), acute renal failure 
(2 cases), and disseminated intravascular coagulation (1 case). There were no cases of 
abruptio placentae, cerebral haemorrhage or maternal death. 
Of all deliveries, perinatal complications included preterm deliveries (45%), low birth 
weight (41%) and still births (17%). 
Conclusion: The prevalence of hypertensive disorders of pregnancy was high but there 



















HELLP SYNDROME:    Haemolysis, elevated liver enzymes, low platelet count 
DIC:                                  Disseminated intravascular coagulation 
MmHg:                             Millimeters of mercury 
PIH:                                  Pregnancy induced hypertension. 
PMH:                                Princess Marina Hospital 
LCH:                                Lilongwe Central Hospital 
ANC                                Antenatal Care. 
SPSS                              Statistical Package for Social Sciences 
WKS                               Weeks 
BP                                    Blood pressure 
mmHg                              millimeters of mercury 
WT                                   weight 
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DEFINITION OF TERMS: 
Hypertensive disorders of pregnancy (HDP): Hypertensive disorders of pregnancy 
include chronic hypertension and Pregnancy Induced Hypertension (PIH).  
Chronic hypertension: If hypertension occurs before 20 weeks of gestation it is 
classified as chronic hypertension. 
PIH: If hypertension occurs after 20 weeks of gestation, during labour or within 48 hours 
of delivery, it is classified as pregnancy induced hypertension (P.I.H).  
Classification of P.I.H 
Hypertension without proteinuria: Two readings of diastolic blood pressure 90-110 
mmHg, 4 hours apart, after 20 weeks of gestation and there is no proteinuria 
Mild PIH: Two readings of diastolic blood pressure 90-110mmHg, 4 hours apart, after 
20 weeks of gestation, with proteinuria up to 2+. 
Severe PIH: Diastolic blood pressure is equal or greater than110mmHg after 20 weeks of 
gestation. There may be severe headache, blurred vision, epigastric pain, hyper-reflexia, 
oliguria (urinary out put equal or less than 400mls/24 hours, proteinuria (protein equal or 
greater than 5g/24hours; dipstick +++), increased weight equal or more than 1000g/week, 
and the patient is conscious. 
Eclampsia: Mother is unconscious and shows typical grand mal seizures or coma. 
Oligohydrouria or unuria is present plus other signs and symptoms of severe pre-
eclampsia (1, 2). 
Perinatal period: The perinatal period comprises the period from 28 completed weeks of 
gestation to the end of 7th completed day of life. 
Birth weight: The birth weight is the weight of a new born infant obtained preferably 
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within one hour of birth. 
Low birth weight (LBW): Refers to the birth weight of less than 2500g (that is up to and 
including 2499g). 
Gestational age: The duration of gestation is measured from the first day of the last 
menstrual period. It is expressed in completed weeks. 
Preterm period: Preterm period refers to less than 37 completed weeks of gestation. 
The term period: Term period starts after 37 completed weeks and continues up to the 
end of 42nd week. 
Post-term period: This period refers to the pregnancy length of more than 42 completed 
weeks of gestation. 
Live births: A live birth has occurred when the new born infant breathes or shows any 
sign of life, such as heart beat, pulsation in the umbilical cord or movements of the 
voluntary muscles. 
Still birth: The birth of a foetus showing no sign of life. For international comparisons of 
perinatal mortality rates still born infants with a birth weight of 1000g or 28 completed 
weeks of gestation are included. 
Still birth rate: Still birth rate is defined as the number of still born infants per 1000 total 
births (still born and live born infants). 
Early neonatal death: This refers to the death of a live born infant during the first 7 days 
of life. 
Late neonatal death: This refers to the death of a live born infant after 7 completed 
days, but before 28 completed days, after birth. 
Perinatal death: Perinatal death comprises the sum of all still births and early neonatal 
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death. 
Perinatal mortality rate: Perinatal mortality rate is the sum of all perinatal deaths in 
relation to the sum of all still born and live born infants.  
Maternal death: Maternal death is death of a woman while pregnant or within 42 
completed days of termination of pregnancy, irrespective of the duration and site of 
pregnancy, from any cause related to or aggravated by the pregnancy or by its 
management but not due to accidental or incidental causes. 
Maternal mortality ratio: Maternal mortality ratio is the number of maternal death per 
















 CHAPTER ONE 
Introduction: Hypertensive disorders of pregnancy (HDP) take a significant tall among 
women suffering from severe maternal morbidity, often resulting in maternal mortality. 
More than 80% of maternal deaths world wide are due to five direct causes: 
haemorrhage, sepsis, unsafe abortion, obstructed labour and hypertensive disorders of 
pregnancy (4). 
The most severe complications of hypertensive disorders of pregnancy are observed in 
poor settings where antenatal diagnosis and management of these diseases are deficient. 
Pregnant women may not complain about subjective symptoms even in advanced stages 
of hypertensive diseases during pregnancy. Thus, the most severe complications, such as 
intra uterine foetal death and eclampsia, may occur without any prior maternal 
complaints. 
Profile of Botswana: 
The Republic of Botswana is a land locked country situated in Southern Africa, nestled 









 FIGURE 1                          




Location: Southern Africa, north of South Africa  
Geographic coordinates: 22 00 S, 24 00 E  
Area: total: 600,370 sq km land: 585,370 sq km water: 15,000 sq km  
Climate: Semiarid; warm winters and hot summers  
Terrain: predominantly flat to gently rolling tableland; Kalahari Desert in southwest  
Natural resources: diamonds, copper, nickel, salt, soda ash, potash, coal, iron ore, silver  
Natural hazards: periodic droughts; seasonal August winds blow from the west, 
carrying sand and dust across the country.  
Environment: Current issues: overgrazing; desertification; limited fresh water resources  
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Geography: landlocked; population concentrated in eastern part of the country(5). 
 Population and demographic characteristics: 
Botswana has a population of 1,680,863 people and a population density of 2.3 people 
per square kilometer. The capital city, Gaborone has a population of 186,007 people and 
a population density of 1100 people per square kilometer. The estimates take into account 
the effects of excess mortality due to AIDS; this can result in lower life expectancy, 
higher infant mortality and death rates, lower population and growth rates and changes in 
distribution of population by age and sex than would other wise be expected.  
The population of Botswana is characterized by youthful nature as 40.3% of the 
population is below 15 years of age. Overall the ratio of male to female is 0.95.  
Life expectancy at birth was 37.13 in 2001 and dropped to 35.29 years in 2002.  It has a 
low fertility rate of 3.7 children born per woman compared to other African countries. 
Literacy rate for total population is 78%; for male it is 75 % and female it is 81% (6, 7).  
 Botswana’s economy:  
Botswana has maintained one of the world’s highest growth rates since independence in 
1966. It has transformed itself from being one of the poorest countries in the world to a 
middle income country with a per capita GDP of $ 6,600 in 2000 (8). 
Diamond mining has fueled much of the economic expansion and accounts for one third 
of GDP and for three quarters of export earnings. Tourism, subsistence farming and cattle 
raising are other key sectors. Unemployment is officially at 19 %, but unofficial estimates 
place it at 40% (8).  
Botswana health services: 
Health care delivery system in Botswana is based on primary health care model which 
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emphasizes on accessibility to basic services. The system is organized into different 
levels based on the complexity of services provided. At the lowest level are mobile health 
stops followed by health posts which serve an area containing less than 500 people. A 
clinic like wise an outpatient facility serves 500 to 1000 people. Primary hospitals with a 
bed capacity of 30 to 70 beds serve as agents of primary health care and perform a range 
of activities which include out patient and general in patient care. Finally there are district 
hospitals and referral hospitals. 
There is one major private hospital; Gaborone Private Hospital. There are 740 mobile 
health stops, 330 health posts, 222 clinics, 17 primary hospitals, 14 district hospitals, and 
three national referral hospitals (9). In the study area Gaborone; there are 3 maternity 
clinics which conduct deliveries, one referral hospital (Princess Marina Hospital), and 
one private hospital (Gaborone Private Hospital). 
Every citizen in Botswana is said to be within a radius of 15 kilometers from professional 
medical help. Antenatal care coverage is over 91% (9). Maternal mortality ratio was 
estimated at 326 per 100,000 live births in 1991 (17) and 330 per 100,000 live births in 
2002 (7). 
The main causes of death were post partum haemorrhage which accounted for 30.8% of 
all deaths, followed by eclampsia which accounted for19.2% and ruptured uterus which 






 HEALTH INDICATORS FOR BOTSWANA (2002): 
________________________________________________________________________
Indicator                                                                                            Measure 
----------------------------------------------------------------------------------------------------------- 
Maternal mortality ratio                                                   330 per 100,000 live births. 
Antennal care coverage                                                     91% 
Skilled attendant at delivery                                              94% 
Infant mortality rate                                                           64.72 per 1000 live births 
Under 5 mortality rate                                                     110 per 1000 live births                                               
___________________________________________________________________ 

















 CHAPTER 2 
BACKGROUND: 
Introduction: This thesis is a report of a retrospective review of medical records of 
patients with hypertensive disorders of pregnancy conducted at PMH, Gaborone, 
Botswana in the period from December 2002 to April 2003. This chapter of the thesis 
presents the epidemiology of the study, specifies the problem of the study, describes its 
significance and presents an overview of the methodology used.  
Epidemiology: Hypertensive disorders of pregnancy include chronic hypertension and 
pregnancy induced hypertension (1, 2). 
Hypertension complicates about 10 % of all pregnancies generally and pre-eclampsia   
Complicate about 5% (2). Eclampsia causes about 12% of all maternal death World wide 
(11). 
Prevalence of HDP varies from country to country. In developed countries the incidence 
of eclampsia and maternal mortality and morbidity related to it decreased during recent 
decades as a result of antenatal care that makes diagnosis and treatment of mild and 
severe cases of pre-eclamsia possible (13). In developing countries prevention and 
detection of high risk groups is difficult because women book late for antenatal care or 
may not attend at all (25).  
Pre-eclampsia tends to be undiagnosed until the condition has reached an advanced stage. 
In the United States of America hypertensive disorders affect about 50 per 1000 women 
and blacks are reported to be more affected than other races; 64.2/1000 and 48.6/1000, 
respectively ( 14). In Saudi Arabia, the prevalence of hypertensive disorders of pregnancy 
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were found to be 30/1000 while in Zimbabwe it was 80/1000 (15) and in South Africa it 
was found to be 46/1000 (16).  
In Botswana, eclampsia was the second cause of maternal death between 1982 and 1988. 
It accounted for 19.2% of all maternal death (17). 
Factors associated with HDP:  
Pre-eclampsia is said to be more common in primigravidae (19, 20). A study done in 
Norway by Skjaeven et al (21) showed that pre-eclampsia was more common in first 
pregnancies and those with prolonged inter-pregnancy interval. Basso et al (22) also 
showed in their study that pre-eclampsia is associated with long inter-pregnancy interval 
rather than change of partners. Twin pregnancy is another risk factor for pre-eclampsia, 
this was confirmed in a study by Leszcynska-Gorzelak et al (24) in Poland. 
High body mass index has also been shown to be a risk factor.  
In their study; Thadhani et al (26), showed that the risk of gestational hypertension 
increased as pre gravid body mass index increased. In a similar study done in Zimbabwe 
by Mahomed et al (15), after adjusting for maternal age, parity and twin pregnancy,  
pre-eclampsia increased with increasing maternal arm circumference. 
Prevention:  Low salt diet and nutritional supplementation with calcium, magnesium, 
zinc, fish liver oil and evening primrose have been used. The efficacy of these measures 
has never been proven in large randomized trials (25). Low dose aspirin has been 
suggested as a preventive agent for women with pre-eclampsia (26). The Magpie trial 




 Clinical significance:  
Maternal outcome: Women who develop high blood pressure in pregnancy are likely to 
have operative delivery and induction of labour compared to the women without 
hypertension (2, 20). They are prone to complications such as hymolysis, elevated liver 
enzymes, and low platelet count (HELLP syndrome), disseminated intra-vascular 
coagulation (DIC), abruptio placentae, pulmonary oedema, and cerebral haemorrhage 
(16, 27). The most common cause of death is related to development of acute respiratory 
syndrome (28) and HELLP syndrome (29). Women with hypertensive disorders of 
pregnancy before 30 weeks of gestation or those with recurrent hypertension in 
pregnancy have an increased incidence of subsequent chronic hypertension (30). 
Foetal outcome: The main impact on the foetus is under nutrition as a result of utero-
placental vascular insufficiency that leads to intra-uterine growth retardation, intra uterine 
foetal death and increased neonatal morbidity and mortality (28, 29). Neonates born to 
women with pre-eclampsia have lower weight and require longer ventilation support (33). 
Severity of hypertension and presence of proteinuria is important in determining foetal 
out come. Buchbinder and Sibai (34) found that there were higher rates of both preterm 
delivery and small for gestation age infants in women with severe gestational 
hypertension compared to women with mild hypertension. Newman MG et al (35) and 
Barton JR et al (36) found that massive proteinuria was associated with earlier gestation 
at delivery, lower birth weight and small for gestation age infants.    
Foetal and neonatal complications are increased in women with chronic hypertension. 
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The risk of perinatal mortality is increased 3-4 times in women with chronic hypertension 
compared to the general obstetric population (37). 
Economic significance: Women with hypertensive disorders of pregnancy stay longer in 
hospital and are likely to have operative delivery and induction of labour thus increasing 
the expenses for both the patients and the health care systems (15, 24, 20, 28). 
Social significance: Women with hypertension in pregnancy spend longer in hospital, 
and this has a disruptive effect on the care of other children (15) and those who die leave 
children without adequate care.     
Rationale for the study: The prevalence, clinical features, complications and outcome of 
pregnancy among hypertensive patients at Princess Marina Hospital, Botswana to our 
knowledge has not been documented, but clinical experience shows that it is a common 
and a serious problem.  Studies conducted in the region for example South Africa (16) 
and Zimbabwe (15) did not classify hypertensive disorders of pregnancy into pre-
eclampsia and pre-existing hypertension. Therefore this study clarifies the different types 
of hypertensive disorders and their prevalence. 
The study was done with view to improve outcome of HDP patients.  
Overview of methodology: 
This was a retrospective study of patients with hypertensive disorders of pregnancy who 
delivered at PMH during the period from December 2002 to April 2003. The study 
population comprised of mothers who delivered during this period and had high blood 
pressure diagnosed during antenatal period, labour or in pueperium. Hypertension in this 
study was taken as a diastolic blood pressure equal to 90 mmHg or more recorded on two 
occasions at least six hours apart. 
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A compilation sheet was used to extract information from patient’s case files.  This 
included the following: demographic data, booking status, antenatal care attendance, 
record of labour and delivery, complications, treatment and perinatal outcome. The   
information collected was coded and entered in the Statistical Package for Social 
Sciences (SPSS) program version 11 for analysis. This study was compared to a similar 
study done at Lilongwe Central Hospital (LCH) in Malawi that was done using similar 
methods and at the same time. 
Limitations of the study: 
Since the information was retrieved from hospital records, some information was missing 
and this may have an effect on the results. The estimation of prevalence may not show a 
true picture since this was referral hospital. But the area prevalence may be representative 













 CHAPTER 3 
OBJECTIVES OF THE STUDY: 
General:  
To determine the prevalence of HDP and the outcome of pregnancy in hypertensive 
women who delivered at PMH, Gaborone, Botswana. 
Specific: 
1. To determine the prevalence of HDP 
2. To determine maternal complications associated with HDP 
3. To determine the foetal outcome of pregnancy in patients with HDP 
4. To determine the characteristics of patients with HDP 













 CHAPTER 4 
METHODOLOGY OF THE STUDY: 
This chapter describes the methodology used in the study. The study was a retrospective 
study where in patient’s records of women with HDP were analyzed.  
Research site:  
The study was carried out at PMH, which is the main referral hospital in Botswana. It is 
situated in Gaborone, the capital city of Botswana. It has 530 beds and about 5,000 
deliveries take place per year (39). 
  Ethical consideration: Permission to carry out the research was obtained from the 
Ethical Committee of Norway, the Presidents Office in Botswana, Gaborone City 
Council and Princess Marina Hospital Ethical Review Board.  
All the information obtained from the patients’ records was handled anonymously and 
confidential. All assistants were PMH employees. Patients’ records were not taken out of 
the hospital premises. 
Study design:  
The study design was retrospective using quantitative methods.  
Study population:    
Study population comprised of women in the reproductive age of 15 to 49 years. They 
were women who were admitted and delivered at PMH with HDP. They were Patients 




Sample size:  
The study population comprised of 1919 deliveries from which cases of HDP were 
obtained. Estimation using the prevalence of HDP for South Africa of 4.6% (11) 
indicated that a population of 1840 would be adequate, since the prevalence for Botswana 
is not known and assuming that since they are in the same region, the prevalence would 
be similar.  
To determine the prevalence with 95% confidence interval between 40 and 60 per 1000 
deliveries, the standard error would be 5/1000. The required population would be: 
N=R/E2      (39) 
N= sample size      R= rate    E= error 
N = (4.6/100)/(0.005)2        =  1840   deliveries.      
 Practically, we included all the women with HDP who delivered at Princess Marina 
Hospital from 1st December 2002 to 30th April 2003. There were three pairs of twins and 
the first twin was included in the study.  
Prevalence was estimated based on the following formula:  
                                         Number of cases of a disease present in 
Prevalence per 1,000=     the population at a specified time             × 1,000 (40) 
                                         Number of persons in the population at 
                                          the specified time 
                                      
Inclusion criteria: 
Cases included in the study had to fulfill the following criteria: 
Women who had a diastolic blood pressure equal to or greater than 90 mmHg with or 
without proteinuria diagnosed after 20 weeks of gestation were included; and women 
with pre-existing hypertension in pregnancy, irrespective of blood pressure measurements 
if they were on treatment. Women who developed hypertension within 48 hours of 
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delivery were also included. 
Exclusion criteria: Pregnant women with normal blood pressure. 
Pre-testing: 
Prior to data collection, the compilation sheet was pre-tested on six files to check if it was 
a good instrument. Some few changes were made to adapt it to the information obtained 
in the files. 
Data collection methods: 
Names and in patient admission numbers were obtained from ward admission and 
discharge books. Names were used to retrieve the in-patient files from the hospital 
records department. 
At PMH, patients’ names are recorded in admission books which are kept in the wards 
and they are also entered in computers in the records department. Patients admitted to the 
hospital are assigned in-patient numbers that are used   even on subsequent admissions. 
On admission, patients are given a file where all particulars of a patient are recorded. 
This includes demographic data of the patients and daily progress on the patients’ 
condition, all procedures performed and all laboratory result are also kept in this file. All 
patients attending antenatal clinics in the government facilities are given antenatal books 
where all information on the patient is written. The information in the antenatal books 
includes demographic data of the patient, past medical history, past obstetric history, 
investigations. The antenatal book is kept by the patient and the patient produces it at 
antenatal clinic on every visit. At each antenatal visit, weight and the symphisis-fundus 
height are recorded. Also blood pressure and urine results are recorded.  
Symphisis-fundus height is routinely measured with a patient in supine position by 
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palpation and using a tape measure, where by the distance between the symphisis pubis 
and fundus is measured in centimeters. At 16 weeks of gestation the fundus is half way 
between the symphisis and umbilicus, at 20 weeks of gestation the fundus is at the 
umbilicus and after 22 weeks fundal height in centimeters is equal to weeks of gestation. 
If there is a discrepancy between weeks of gestation from the last menstrual history and 
the measured symphisis-fundus height by 2-3 cm this would indicate; intra uterine growth 
retardation, twin pregnancy, polyhydroamnios or wrong dates and in this case a patient 
would be referred for ultra sound assessment.  
Proteinuria is routinely measured using dip sticks on each antenatal visit. In patients with 
heavy proteinuria, a 24 hour urine protein assessment would be done.  
  The antenatal book also has a patogram where progress of labour and delivery are 
recorded.  On discharge, the antenatal book is retained at the hospital and is kept in the 
in-patients file together with her other in-patient records.  
For the study, information obtained from in-patient files and antenatal books was entered 
into a compilation sheet. Total number of deliveries in the study period was obtained 
from delivery register which is kept in labour ward. We also counted the number of 
deliveries in three maternity clinics in Gaborone City Council, namely; Old Naledi 
Clinic, Gaborone West Clinic, Tsholofelo Clinic and Gaborone Private Hospital for the 
same period so that the area prevalence could be estimated.   
Results obtained from the research conducted at PMH were compared with the results of 




Data analysis: Information obtained from patients case records was coded and entered in 
SPSS computer program version 11 and analyzed. Statistical analysis was performed 
using the Chi-square on categorical variables.  
One way between-groups analysis of variance (ANOVA) was used to compare outcome 
in different groups of patients, that is; those with hypertension without proteinuria, mild 
pre-eclampsia and severe pre-eclampsia. Independent sample t-test was used to compare 
mean scores of continuous variables for Princess Marina Hospital and Lilongwe Central 

















 CHAPER 5 
SUMMARY OF THE RESULTS:  
This chapter summarizes results presented in articles 1 and 2.  
Article 1  
Hypertensive disorders of pregnancy, complications and obstetric outcome at 
Princess Marina Hospital, Gaborone, Botswana. 
Nkubito GK, Stray-Pedersen B, Hussain A  
OBJECTIVES: To determine the prevalence, maternal complications, foetal outcome and 
characteristics of patients with HDP. 
SETTING: Princess Marina Hospital, a tertiary and referral Hospital in Gaborone, 
Botswana. 
MATERIALS AND METHODS:  A retrospective chart review of all hypertensive 
women who delivered at PMH from December 2002 to April 2003 was done. 
Information from patients’ records was entered on a compilation sheet which was entered 
in SPSS program and analyzed. Prevalence rates (per 1000 deliveries) were estimated by 
type of hypertension. Demographic characteristics, maternal complications and perinatal 
outcome were also determined. 
RESULTS: Of 1919 deliveries at Princess Marina Hospital during the study period, there 
were 100 cases of hypertensive disorders of pregnancy giving a prevalence of 52.1 per 
1000 deliveries. Twenty one cases had chronic hypertension of which 11 (52%) 
developed superimposed pre-eclampsia while 10(48%) had no proteinuria.  
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Of 79 patients with pregnancy induced hypertension, 36 (46%) had hypertension without 
proteinuria, 42(53%) had pre-eclampsia and 1(1%) had eclampsia. 
Age ranged from 18 to 47 years with a mean age of 29.5 years. Teenagers were 8 cases 
out of 100. Maternal complications were HELLP syndrome (3 cases), acute renal failure 
(2 cases), and disseminated intravascular coagulation (1 case). There were no cases of 
abruptio placentae, cerebral haemorrhage or maternal death. 
Of all deliveries, perinatal complications included preterm deliveries (45%), low birth 
weight (41%) and still births (17%). 
Conclusion: The prevalence of hypertensive disorders of pregnancy was high but there 















 ARTICLE 2 
 
Hypertensive Disorders of Pregnancy: Prevalence, Maternal complications and 
Perinatal Outcomes at Princess Marina Hospital in Botswana and Lilongwe Central 
Hospital in Malawi: A Comparative Study. 
 
 AUTHORS: Nkubito GK, Kilembe FD, Hussain A, Stray-Pedersen B. 
  
The studies were carried out at Princess Marina Hospital (PMH) in Botswana and 
Lilongwe Central Hospital (LCH) in Malawi. 
Objectives of the study were to determine and compare the prevalence, maternal 
complications and foetal outcome for Botswana and Malawi. 
  
MATERIALS AND METHODS: A retrospective study was done by reviewing patients’ 
medical records who delivered at PMH from December 2002 to April 2003 and LCH 
from January 2003 to June 2003. Those with HDP were then selected for the study. The 
studies were done in the two hospitals separately using similar methods and the results 
compared. 
 
RESULTS:  Of the 1919 women, who delivered at PMH; 100 had hypertensive disorders 
of pregnancy giving a prevalence rate of 52.1per 1000 deliveries. Out of 100 cases, 53 
patients had pre-eclampsia and one had eclampsia, and these were eligible for a 
comparative study.  
Of 5248 deliveries at LCH only 70 women had hypertensive disorders of pregnancy, thus 
the prevalence rate was only 13 per 1000 deliveries. All the 70 patients at LCH had either 
pre-eclampsia or eclampsia and were eligible for a comparative study. There were 
significant differences in antenatal care of the hypertensive patients: 94% in PMH as 
compared to 51% in LCH (p=0.0001). At LCH, 66% (n=46) of the cases had pre-
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eclampsia of which 41% (n=29) had mild pre-eclampsia and 24% (n=17) with severe pre-
eclampsia and 34 % (n=24) had eclampsia of whom one died.  
At Princess Marina Hospital, of the 54 cases, 34 had mild pre-eclampsia, 19 had severe 
pre-eclampsia and 1 had eclampsia. 
With regards to perinatal outcome, 52% (n=28) of Princess Marina patients had low birth 
weight babies compared to 39% (n=27) at Lilongwe Central Hospital. The frequency of 
preterm delivery was similar, 54% (n=29) in Princess Marina patients and 47% (n=34) at 
Lilongwe Central Hospital. 
CONLUSION:  Prevalence of hypertensive disorders of pregnancy was lower at 
Lilongwe Central Hospital which might be due to unrecorded home deliveries. There 
were more maternal complications at Lilongwe Central Hospitals which may be 
attributed to under utilization of antenatal care services. 
 
RECOMMENDATIONS: 
We recommend that antenatal care coverage in Malawi should be increased so that 
patients who are at risk of developing hypertensive disorders of pregnancy are monitored 
and also to prevent those with hypertension in pregnancy to progress to severe forms.  
The high rate of chronic hypertension at Princess Marina Hospital may be due to the fact 
that most women were old and most likely they had essential hypertension, but more 
investigations should be done to find out if there are other underlying causes. Another 
reason for high prevalence of chronic hypertension may be due to the fact that women 
presented early for antenatal care and this made diagnosis possible. Women with chronic 
hypertension need close monitoring to avoid perinatal complications. 
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Article 1 
HYPERTENSIVE DISORDERS OF PREGNANCY, COMPLICATIONS AND 
OBSTETRIC OUTCOME AT PRINCESS MARINA HOSPITAL, GABORONE, 
BOTSWANA. 
      Nkubito GK, Stray-Pedersen B, Hussain A. 
 ABSTRACT 
 OBJECTIVES: To determine the prevalence, maternal complications, foetal outcome 
and characteristics of patients with hypertensive disorders of pregnancy. 
Setting: Princess Marina Hospital (PMH), a tertiary and referral Hospital in Gaborone, 
Botswana. 
MATERIALS AND METHODS:  A retrospective chart review of all hypertensive 
women who delivered at PMH from December 2002 to April 2003 was done. 
Information from patients’ records was entered on a compilation sheet which was entered 
in SPSS program and analyzed. Prevalence rates (per 1000 deliveries) were estimated by 
type of hypertension. Demographic characteristics, maternal complications and perinatal 
outcome were also determined. 
RESULTS: Of 1919 deliveries at PMH during the study period, there were 100 cases of 
hypertensive disorders of pregnancy giving a prevalence of 52.1 per 1000 deliveries. 
Twenty one cases had chronic hypertension of which 11 (52%) developed superimposed 
pre-eclampsia while 10(48%) had no proteinuria.  
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Of 79 patients with pregnancy induced hypertension, 36 (46%) had hypertension without 
proteinuria, 42(53%) had pre-eclampsia and 1(1%) had eclampsia. 
Age ranged from 18 to 47 years with a mean age of 29.5 years. Teenagers were 8 cases 
out of 100. Maternal complications were HELLP syndrome (3 cases), acute renal failure 
(2 cases), and disseminated intravascular coagulation (1 case). There were no cases of 
abruptio placentae, cerebral haemorrhage or maternal death. 
Of all deliveries, perinatal complications included preterm deliveries (45%), low birth 
weight (41%) and still births (17%). 
Conclusion: The prevalence of hypertensive disorders of pregnancy was high but there 
















Hypertensive disorders of pregnancy include chronic hypertension in pregnancy and 
pregnancy induced hypertension. Hypertension complicates about 10% of all pregnancies 
generally and pre-eclampsia complicates about 5%. Eclampsia accounts for about 12% of 
all maternal death World wide. 
In Botswana eclampsia was the second cause of maternal mortality between 1982 and 
1988. Hypertensive disorders of pregnancy are most common cause of in patient obstetric 
morbidity in Botswana. The prevalence, complications and perinatal outcome in Princess 
Marina Hospital has not yet been documented. We there fore carried out this research to 
determine the prevalence of hypertensive disorders of pregnancy, maternal complications 
and foetal out come in hypertensive patients with a view to improve outcome of 
deliveries. 
MATERIALS AND METHODS: This was a retrospective study of patients with 
hypertensive disorders of pregnancy who delivered at PMH from December 2002 to 
April 2003. Hypertension was diagnosed in antenatal period, during labour and within 48 
hours post partum period. Hypertension was defined as a diastolic blood pressure equal or 
greater than 90mmHg recorded on two occasions at least 4-6 hours apart. Proteinuria was 
significant when two random samples taken 4-6 hours apart tested 1+ or more on reagent 
strip or one 24 hour urine collection with a total protein excretion equal or greater than 
300mg/24 hours. 
Chronic hypertension was defined as hypertension which occurs before 20 weeks of 
gestation; if hypertension occurs after 20 weeks of gestation, during labour or within 48 
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hours of delivery is classified as Pregnancy Induced Hypertension (PIH). 
Pregnancy induced hypertension was classified into 4 categories depending on the 
severity and presence of proteinuria: hypertension without proteinuria, mild pre-
eclampsia, severe pre-eclampsia and eclampsia. 
 Ethical clearance was obtained from Norway ethical committee, Office of the President, 
Botswana, Gaborone City Council and Princess Marina ethical review board.    
Total number of deliveries was obtained from birth registers at Princess Marina Hospital, 
Old Naledi clinic, Gaborone West Clinic, Tsholofelo Clinic and Gaborone Private 
Hospital. A compilation sheet was used to extract information from the patient’s case 
records. The information extracted included demographic data, booking status, antenatal 
care attendance, records of labour and delivery, maternal complications, investigations, 
treatment and perinatal outcome. 
Information obtained was coded and entered in SPSS version 11.0 program and analyzed.  
Statistical analysis was performed using the Chi-square on categorical variables. One way 
between-groups ANOVA was used to compare outcome in different groups of patients, 
that is; those with hypertension without proteinuria, mild pre-eclampsia and severe pre-








RESULTS OF THE STUDY: 
During the study period from December 2002 to April 2003 there were 1919 total 
deliveries at Princess Marina Hospital and 988 for Gaborone City council clinics and 
Gaborone Private Hospital. Thus the total number of deliveries in the whole of Gaborone 
City was 2907. There were 100 cases that fulfilled the criteria of HDPthus giving a 
prevalence of 52.1 per 1000 deliveries. The area prevalence was estimated using the total 
number of deliveries in Gaborone (this included deliveries conducted in maternity clinics 
in Gaborone City Council, Gaborone Private Hospital and Princess Marina Hospital) and 
was found to be 34.4 per 1000 deliveries. City council clinics refer all cases of HDP and 
it was assumed that there were few cases who delivered at Gaborone Private Hospital 
with HDP.  
Twenty one cases had chronic hypertension in pregnancy of which 11 developed pre-
eclampsia while 10 cases had hypertension without proteinuria. Thus the prevalence of 
chronic hypertension in pregnancy was 10.9 per 1000 deliveries. 
Seventy nine cases had pregnancy induced hypertension of which thirty six cases (46%) 
had hypertension without proteinuria, 42(53%) had pre-eclampsia and one case (1%) had 
eclampsia. 
The prevalence of pre-eclampsia was 28 per 1000 deliveries and that of eclampsia was 
0.5 per 1000 deliveries. 
Most of patients with HDP were referrals. Referrals were 93 out of 100 cases. Of the 
referral cases, 83 were from Gaborone City Council Clinics, 4 were from primary 
hospitals, 6 were from district hospitals. It was not indicated whether 2 remaining cases 
were referrals or not. 
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Demographic features of the study group:  
Age: Age ranged from 18 to 47 years, with a mean age of 29.55 years and standard 
deviation of 7.89. Teenagers comprised 8 of all 100 hypertensive cases. 
Marital status: Of all hypertensive cases, 26 were married, 70 were single, and 2 were 
widows and 2 of them marital status was not known.  
Gravidity: Gravidity ranged from 1 to 10. Primigravidae were 32, gravidae 2 to 3 
comprised of 38, gravid 4 to 5 comprised of 19 and gravid 6 and more comprised of 11. 
Antenatal care attendance: Majority of patients with hypertension had booked for 
antenatal care (n=95), only 3 had not booked and the status was not known for 2 patients. 
The gestation age for booking ranged from 10 to 36 weeks of gestation. 
Seventy percent of the cases had booked for antenatal care by 24 weeks of gestation, only 
4% of the hypertensive cases booked in the first trimester. Women with severe pre-
eclampsia were less likely to book for antenatal care compared to women with mild pre-
eclampsia and hypertension without proteinuria, p-value=0.001 (table 1).   
Clinical features  of the study group: 
Blood pressure on admission:  
The diastolic blood pressure on admission ranged from 90 to 180 mmHg. 
 Systolic blood pressure ranged from 140 to 240 mmHg.  
Oedema on admission: 
On admission, 37 patients had no oedema, 21 had mild oedema, 24 had moderate oedema 
while 8 had generalized oedema and information was missing for ten cases. 
Oedema was more common in patients with severe pre-eclampsia compared to those with 
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mild pre-eclampsia and those without proteinuria, p-value=0.03(table1). 
Drug regimens used to treat hypertension: 
 Most of the hypertensive patients (n=87) required methyldopa to control the blood 
pressure, 73 required nifedipine, 34 required hydrallazine while only 4 were given 
magnesium sulphate. One patient who had eclampsia was given magnesium sulphate 
therapeutically while the other 3 were given for prophylaxis because of severe pre 
eclampsia. 
Diazepam was given to 3 patients at district hospital and one patient was on enalapril for 
control of blood pressure and another was given phenobarbitone for controlling seizures 
which was also prescribed at a district hospital. 
Delivery: 
Gestation: The minimum gestation age at delivery 24 weeks while the maximum was 44 
weeks. There were 45 preterm deliveries, 50 were term deliveries and information was 
missing for 5 of cases. Pre-term delivery was more common in patients with severe pre-
eclampsia compared to those with mild pre-eclampsia and those without proteinuria, p-
value=0.001 (table 2). Blood pressure: Diastolic blood pressure at delivery ranged from 
60mmHg to 150mmHg while systolic blood pressure ranged from 140 to 190mmHg. This 
shows that most patients’ blood pressure had been controlled at delivery. 
 Mode of delivery: 
Information on mode of delivery was available for 95 of cases and it was missing for 5. 
Forty-three of cases delivered by spontaneous vertex delivery, 28 were induced, 21 
delivered by Caesarian section and 3 delivered by vacuum extraction. Caesarian section 
rate was 21 % among hypertensive cases compared to 16% in general obstetric 
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population. 
Maternal complications:  
The rate of complications was low during the study period; only 3% (n=3) of cases had 
HELLP syndrome, 2% (n=2) had acute renal failure, one (1%) had disseminated 
intravascular coagulation and one(1%) had eclampsia. There was no case with pulmonary 
oedema or cerebral pathology, there were no abruptio placentae and there was no 
maternal death related to hypertensive disorders of pregnancy during the study period. 
Foetal outcome:  
Foetal outcome of pregnancy in hypertensive women indicates that there were more 
males (n=50) than females (n=44), information about sex was not available for six babies. 
There were 45 preterm deliveries and 50 term deliveries and information was not 
available for 5 cases. Forty-one of neonates had low birth weight (wt <2500g), 51 had 
weight equal or greater than 2500 grams and information was missing for 8 neonates. 
There were 78 live births, 17 still births and information was missing for 5 cases. Of the 
still birth; 12 were macerated while 5 were fresh. Still-birth rate was calculated at 170 per 
1000 total birth compared to 16.7 per 1000 total birth in general obstetric population. 
Low birth weight and still births were more common in women with severe pre-
eclampsia, p-value =0.001 and 0.001 respectively (table 2). 
Neonates born to women with severe pre-eclampsia and eclampsia had lower Apgar score 
compared to neonates born to women with mild pre-eclampsia and those without 
proteinuria at zero, five and ten minutes; P-value=0.001, 0.001, 0.001 respectively (table 
2). Low birth weight accounted for 42 out of 100 deliveries.  
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 DISCUSSION:  
In this chapter results of the current study are discussed. The study determines the 
prevalence of hypertensive disorders of pregnancy, complications and foetal outcome of 
hypertensive pregnancies in a national referral hospital. Hypertensive disorders of 
pregnancy accounted for 5.2% of all the deliveries at Princess Marina Hospital and there 
were no deaths related to hypertensive disorders of pregnancy in the study period. This is 
greater than the prevalence for Umtata General Hospital, South Africa which was 4.6% 
(1) and that of Kuwait which was 4.9% (2). This rate was lower than that reported in 
Harare maternity hospital in Zimbabwe which was 8% (3). The prevalence of 
hypertensive disorders of pregnancy was higher than that reported in Saudi Arabia by Al-
Ghamdi et al of 3% (4) and Senegal by Thiam M, Goumbala et al of 3.9% (59) 
The prevalence of pregnancy induced hypertension was less than that reported for U.K of 
5% (6) but higher that that reported in the U.S of 3.6% by Anath et al 1995. 
Maternal complications in this study included HELLP syndrome, acute renal failure and 
disseminated intravascular coagulation (DIC), there were no cases of abruption placentae, 
pulmonary oedema or maternal death. There were fewer complications than those 
reported in neighbouring countries like South Africa (1) and Zimbabwe (3) this could be 
due to high rate of antenatal attendance in Botswana which 95% in this study compared 
to 54.7% at Umtata General Hospital which made diagnosis and prevention of severe 
complications possible. 
Women with chronic hypertension were at high risk of developing superimposed  
pre-eclampsia this was associated with high rates of adverse perinatal  and maternal 
outcomes. Eleven (52%) women out of 21 with chronic hypertension developed 
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superimposed pre-eclampsia, while half of them had adverse perinatal outcome. The rate 
of pre-eclampsia in women with chronic hypertension was higher than that in other 
studies which reported rates which range from 10% to 25% in mild hypertension and rate 
in severe chronic hypertension is said to reach around 50% ( 8). The rate of pre eclampsia 
in chronic hypertension patients in this study was higher than that reported in Saudi 
Arabia by Al-Ghamdi et al who reported a rate of 47%.Therefore patients with chronic 
hypertension should be managed to reduce the maternal risks and achieve optimal 
perinatal survival. Management should include pre conceptual evaluation and counseling, 
early antenatal care, frequent antepartum visits to monitor both maternal and foetal well-
being, timely delivery and with intensive intrapartum monitoring and proper postpartum 
management (8). 
Foetal complications were low birth weight 41 (41%), intra uterine foetal deaths 17 
(17%) and early neonatal death 2 (2%). Low birth weight rate was high in patients with 
HDP compared to the low birth weight in general obstetric population which was 20%. 
Still birth rate was 170/1000 births compared to 16.7/1000 still births in general obstetric 
population during the study period at Princess Marina Hospital. 
Other studies have shown that hypertensive pregnancies were associated with increased 
perinatal mortality and morbidity (9). 
In this study, low birth weight and still births were more common in patients with severe 
hypertension compared to those with mild hypertension. 
Maternal age, gravidity, multiple pregnancies, obesity are reported to be a risk factors for 
pre eclampsia. In our study primigravidae constituted only 32(32%) of all hypertensive 
patients and this could be because of a big number of multigravidae with chronic 
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hypertension and some of them may have been un-diagnosed.  
Fifty three percent (n=17) of the primigravidae had pre-eclampsia. Teenagers formed 
only 8% of all hypertensive cases. 
In conclusion, the prevalence of hypertensive disorders of pregnancy is high at PMH and 
Gaborone City Council at large and there is increased maternal and perinatal morbidity. 
Pre existing hypertension contributes a great deal to the maternal and foetal morbidity 





















Maternal demographics and symptoms reported by the study population. 
Variable                  hypertension without                                       severe              p-value 
                                Proteinuria                      mild pre-eclampsia  pre-eclampsia 
                                N=46                               N=34                        and eclampsia  
                                                                                                          N=20 
________________________________________________________________________ 
Age(yrs)                       30.1±7.5                   28.7±7.9                 29.7±7.9           0.73(NS) 
Gravidity                        3.2±2.1                     2.9±2.3                    2.5±1.7          0.46(NS) 
Booked for ANC(%)  100                            100                            83                    0.001(S) 
Gestation 
at booking(Wks)           21.4±6.4                   21.9±5.4                   19.9±4.9         0.26(NS)                                
ANC visits(number)       6.3±2.8                     6.6±3.0                     5.4±2.8         0.26(NS) 
Diastolic BP  
On admission(mmHg)100.7±12.0                  96.8±6.7                123.4±16.9      0.001(S) 
 
Oedema(%)                  38                               70                            65                  0.03(S)                                   
Headache(%)                28                               18                            45                  0.05(NS)                
Dizziness(%)                13                              12                            25                   0.67(NS)              
Epigastric pain(%)       15                                3                             25                  0.18(NS)                  
Visual disturbance(%)   0                                3                               5                  0.89(NS)                    
Nausea +vomiting(%)    3                                0                             10                  0.64(NS)  
 
________________________________________________________________________                 
                   






















Maternal and foetal out come for the study population. 
Variable                  hypertension without        mild                  severe                      p-value 
                                Proteinuria                        pre-eclampsia   pre-eclampsia 
                                N=46                                N=34                 and eclampsia  
                                                                                                   N=20                                                                 
________________________________________________________________________ 
 
HELLP syndrome(%)      0                                  0                            15                 0.001(S) 
DIC (%)                           2                                  0                               0                0.56(NS) 
ARF(%)                           0                                  3                                6               0.34(NS) 
C/section(%)                  18                                32                              15               0.07(NS) 
Length of 
gestation(WKS)             38±4                             37±4                         34±3           0.001(S) 
Preterm delivery(%)      38                                 38                              70               0.001(S) 
Low birth WT(%)          35                                 44                              60              0.001(S) 
Birth WT(G)              2797.8±814.5               2613±849.9               1996±882.4   0.001(S) 
Still births (%)                13                                12                              37               0.001(S) 
Average still  
birth WT(G)                1578±432                    1412±548                  1251±428      0.48(NS) 
Apgar score at 0min          7±3                               6±3                          4±4           0.001(S) 
Apgar score at 5min          8±2                               7±3                          5±5           0.001(S) 
Apgar score at 10min        9±1                               8±2                          5±5           0.001(S)          
________________________________________________________________________ 
                 
HELLP= Haemolysis, elevated liver enzymes, low platelet count 
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Hypertensive Disorders of Pregnancy: Prevalence, Maternal complications and 
Perinatal Outcomes at Princess Marina Hospital in Botswana and Lilongwe Central 
Hospital in Malawi: A Comparative Study. 
 
 AUTHORS: Nkubito GK; Kilembe FD, Hussain A, Stray-Pedersen B. 
  
ABSTRACT: 
Objectives of the study were to determine and compare the prevalence, maternal 
complications and foetal outcome for Botswana and Malawi. 
 MATERIALS AND METHODS: A retrospective study was done by reviewing patients’ 
medical records who delivered at Princess Marina Hospital (PMH) from December 2002 
to April 2003 and Lilongwe Central Hospital (LCH) from January 2003 to June 2003. 
Those with hypertensive disorders of pregnancy were then selected for the study. The 
studies were done in the two hospitals separately using similar methods and the results 
compared. 
RESULTS:  Of the 1919 women, who delivered at PMH; 100 had hypertensive disorders 
of pregnancy giving a prevalence rate of 52.1per 1000 deliveries. Out of 100 cases, 53 
patients had pre-eclampsia and one had eclampsia, and these were eligible for a 
comparative study.  
Of 5248 deliveries LCH only 70 women had hypertensive disorders of pregnancy, thus 
the prevalence rate was only 13 per 1000 deliveries. All the 70 patients at LCH had either 
pre-eclampsia or eclampsia and were eligible for a comparative study. There were 
significant differences in antenatal care of the hypertensive patients: 94% in PMH as 
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compared to 51% in LCH (p=0.0001). At LCH, 41.4% (n=29) had mild pre-eclampsia, 
24.3% (n=17) and 34.3 % (n=24) had eclampsia.  
At PMH, of the 54 cases, 63% (n=34) had mild pre-eclampsia, 35% (n=19) had severe 
pre-eclampsia and 2% (n=1) had eclampsia. There were 4% (n=3) cases of acute renal 
failure at LCH and 4% (n=2)  at PMH. There were 4% (n=2) cases of HELLP syndrome 
at PMH and none recorded at LCH.  
With regards to perinatal outcome, 56% of PMH patients had low birth weight babies 
compared to 41% at LCH. The frequency of preterm delivery was similar, 57% in PMH 
and 55% at LCH.  
CONLUSION:  Prevalence of hypertensive disorders of pregnancy was lower at LCH 
which might be due to unrecorded home deliveries. There were more maternal 













 INTRODUCTION:  
Hypertensive disorders of pregnancy include chronic hypertension in pregnancy and 
pregnancy induced hypertension. Hypertension complicates about 10% of all pregnancies 
and pre-eclampsia complicates about 5% (1). Eclampsia accounts for 12% of all maternal 
deaths word wide (2). The most severe complications of hypertensive disorders of 
pregnancy are observed in poor settings where antenatal diagnosis and management of 
these diseases is deficient. This article is a comparison of two researches carried out in 
LCH, Malawi and PMH, Botswana on patients who had pre-eclampsia and eclampsia in 
the period December 2002 to April 2003 for PMH and January to June 2003 for LCH.  
 Malawi is in South-Eastern Africa and Botswana in Southern Africa. The two countries 
are different in terms of economy; Malawi being a low income country and Botswana 
being a middle income country. Health indicators for the two countries are different. 
Maternal mortality ratio in Malawi is 1120 per 100,000 live births while in Botswana it is 
330 per 100,000 live births. Antenatal care attendance for the two countries is officially 
91% while skilled attendance at delivery for Malawi is 56% and for Botswana is 94% (3). 
In Malawi almost half of the women are delivered at home by relatives or traditional birth 
attendants while in Botswana hospital/clinic deliveries are common.  
The purpose of this article is to compare the prevalence, maternal complications and fetal 
outcome in patients with pre-eclampsia and eclampsia in Malawi and Botswana with 




 MATERIALS AND METHODS:    
This was a comparison of two studies done in Malawi and Botswana on pre-eclampsia 
and eclampsia. In both studies retrospective review of medical records was done for 
patients who delivered in the period from December 2002 to April 2003 for PMH and 
from January to June 2003 for LCH. Cases that had pre-eclampsia and eclampsia were 
compared. Cases excluded were those who had hypertension without proteinuria. This is 
because there were no recorded cases of hypertension without proteinuria at LCH while 
they were 46 of 100 at PMH.  
Mild pre-eclampsia was defined as two readings of diastolic blood pressure 90 to 
110mmHg, 4 to 6 hours apart, after 20 weeks of gestation and proteinuria. 
Severe pre-eclampsia, the diastolic blood pressure is equal or greater than110 mmHg 
after 20 weeks of gestation. There may be severe headache, blurred vision, epigastric 
pain, hyper reflexia, oliguria, proteinuria (protein equal or greater than 5g per 24 hours or 
dipstick 3+), and increased weight equal or more than 1000gm per week and the patient is 
conscious. 
A compilation form was used to extract information from patient’s case records.  The 
information included demographic data, booking status, antenatal attendance, records of 
labour and delivery, complications and perinatal outcome.  
The information obtained was coded and entered in SPSS version 11.0 and analyzed. 
Descriptive statistics were worked out. Cases from the two hospitals were compared 




During the study period, out of 1919 total deliveries at PMH, there were 53 cases of pre-
eclampsia and one case of eclampsia giving a prevalence of 28 per 1000 deliveries. Out 
of 5248 deliveries at LCH, there were 70 cases that fulfilled the inclusion criteria of 
which 46(66%) had pre-eclampsia and 24(34%) had eclampsia giving the prevalence of 
13 per 1000 deliveries.  
Demographic characteristics study population:  
Age: The age range of PMH patients was from 18 to 47 with a mean of 29.4 years, 
teenagers were 3(5.6%)  while for LCH cases age range was from 16 to 41 with a mean 
of 23.9 years and teenagers were 5(10.9%). As observed on table 1 patients were younger 
at LCH compared to PMH patients (P=0.001). 
Gravidity: Gravidity for PMH cases ranged from 1 to 10 pregnancies with a mean of 2.9 
while at LCH it ranged from 1 to 7 with a mean of 2.2 pregnancies. No statistical 
significance was observed between the two hospitals. 
Education: Patients at PMH had higher education than LCH patients. Seventy two 
percent 72%(n=39) of PMH patients had secondary education and higher compared to 
40%(n=28) at LCH (P=0.02). 
Marital status:  Ninety three percent (n=65) of LCH cases were married compared to 
only 18% (n=10) of PMH patients (P=0.001). This difference may be due to cultural 
differences in the two countries. 
Antenatal management:  
Ninety four percent (n=51) of PMH patients had booked for antenatal care while only 
51% (n=36) at LCH had been booked (P=0.001). More over 52% of the cases at PMH 
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had booked by 24 weeks of gestation compared to 1% at LCH (P=0.001). Patients at 
LCH and PMH had made an average of 2 and 6 visits respectively by the time of delivery 
(P=0.001).  
Regarding drug treatment, there were no standardized regimens in both hospitals. 
Monotherapy with Methyldopa was commonly used at both hospitals for mild pre-
eclampsia with some patients in the same category not getting any drug therapy. Both 
hospitals had various combined therapies for treatment of severe pre-eclampsia but with 
diazepam added in the treatment of severe pre-eclampsia and eclampsia at LCH while 
magnesium sulfate was added for impending eclampsia at PMH.  
Reported symptoms: 
The most common symptom was headache followed by epigastric pain. As observed in 
table 2, LCH cases had more symptoms than PMH cases. The cases were also more 
severe at LCH. 
Delivery: 
There were 54% (n=29) pre-term deliveries for PMH and 49% (n=34) for LCH.  
Induction of labour was more common at PMH where 20 (37%) of cases were induced; 
there was no record of induction of labour at LCH. Caesarian section rate at PMH was 13 
(24%) compared to 25 (36%) at LCH (p= 0.10). 
Maternal complications: 
There were more maternal complications at LCH compared to PMH. Thirty four percent 
(n=24) of LCH patients had eclampsia compared to only two percent (n=1) of the cases at 
PMH. Acute renal failure was observed in the similar frequency, 4% (n=3) of LCH 
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patients and 4% (n=2) of PMH patients. HELLP syndrome was reported in 4% (n=2) of 
patients at PMH and none at LCH.  
Perinatal out come: 
There were more low birth weight babies at PMH 52% (n=28) than LCH 39%(n=27) 
(P=0.11). There were 12 (22%) still birth at PMH compared to 7 (10%) at LCH. There 




















We compared pre-eclampsia and eclampsia frequency of two African countries with 
different economical background. Botswana situated in Southern Africa has a middle 
economy while Malawi situated in South East Africa is among the least developing 
countries. We compared patients referred to comparable referral hospitals. The 
prevalence of pre-eclampsia at PMH was 28 per 1000 deliveries. The prevalence of pre-
eclampsia at LCH was 8 per1000. There were 24 eclamptic cases at LCH and one 
eclamptic case at PMH. The trend of eclampsia in these two hospitals confirms previous 
studies that established a relationship between high maternal mortality ratios with 
increased eclampsia (4). Malawi has a maternal mortality ratio of 1120 per 100,000 live 
births as compared to 330 per 100,000 live births for Botswana. The higher cases of 
eclampsia at LCH are attributed to underutilization of antenatal care. Only 36 (51%) 
patients at LCH booked for antenatal care as compared to 51(94%) patients who booked 
for antenatal care at PMH. In Botswana the women came significantly earlier and had 
more visits than in Malawi patients. A good and regular antenatal care with screening for 
high risk pregnancies and quality treatment prevents hypertensive cases to progress into 
eclamptic stage (5, 6, 7, 8). Primigravidity was a prominent characteristic of patients with 
pre-eclampsia and eclampsia at both (PMH and LCH) hospitals with 31% (n=17) and 
50% (n=35) affected respectively. This is in agreement with previous studies (6, 9, 10).  
Teenage pregnancy was not a common characteristic of patients in our study, but young 
age (16 to 24 years) was significantly affected by pre-eclampsia and eclampsia. Other 
characteristics for pre-eclampsia and eclampsia such as previous history of pre-
eclampsia, twin pregnancies, heredity (family history), and body mass index were not 
studied in detail due to limited of available data. Pre-eclampsia and eclampsia are known 
for adverse maternal outcomes (10, 11, 12).  
In our studies, there were more maternal complications at LCH than PMH. At PMH two 
cases developed HELLP syndrome, two had acute renal failure and no maternal death 
while at LCH there 24 eclamptic cases, three cases with acute renal failure and one 
maternal death.  
Regarding the perinatal outcome, we found higher still births at PMH 12 (22%) as 
compared to 7 (10%) at LCH.  
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Our findings, show that at PMH 28 (52%) had low birth weight babies compared to LCH 
with 27(39%). This could be due to high rate of induction of labour at PMH.  
Severe cases of HDP such as severe pre-eclmpsia and eclampsia result into preterm 
deliveries. Our studies established that of the severe pre-eclamptic patients, 15(75%) at 
PMH had preterm deliveries while at LCH they were 7(41%).  Amongst the eclamptic 
patients (n=24) at LCH, 17 (71%) of them had preterm deliveries (table 3). Severe 
preterm (those who delivered at 32 weeks or less), were 18% at PMH and 14% at LCH 
but this was not statistically significant (P=0.50). Preterm delivery and low birth weight 
were also not statistically different in the two countries.  
Most patients at both hospitals progressed into spontaneous vaginal delivery with 20 
patients (37%) induced at PMH and no record of induction of labour at LCH. In the latter 
hospital most of the patients came in a critical stage necessitating caesarian section. In 
fact caesarian section was done mostly in mild preeclampia at PMH while at LCH it was 
mostly done on severe cases such as eclampsia. Thirteen (54%) of the 24 eclamptic 
patients at LCH were delivered by caesarian section. 
 Many previous studies have tried to establish a standard treatment but there is no global 
adopted regimen, hence different regimes were used at PMH and LCH respectively.  
In conclusion, the prevalence in Botswana is greater than that of Malawi. Maternal 
complications were more at LCH. There were no statistical differences in the foetal 
outcome between the two hospitals. The poor maternal outcome at LCH may be 










LIST OF TABLES: 
Table 1 
  
Patients’ characteristics, maternal complications and foetal outcomes at PMH and LCH. 
 
Hospital                                               PMH N=54            LCH N=70               p value 
Demographic features: 
Mean maternal age (yrs)                     29.4±8.0               23.9±5.3                   0.001(S) 
Parity (mean)                                        1.7±2.0                 1.1±1.6                   0.10(NS) 
Secondary  
Education and higher                          39 (72%)                    28(40%)             0.001(S) 
 
Antenatal care: 
Booked for antenatal visit                   51(94%)               36(51%)                 0.001(S) 
Gestational age at booking (weeks)    21.2±5.2               33.5±4.8                 0.0001(S) 
Gestational length (weeks)                  36±4                     36±4                      0.66(NS) 
Average number of ANC visits             6                            2                          0.001(S) 
 
Maternal complications 
Eclampsia                                               1(2%)                  24( 34%)              0.001(S) 
Maternal death                                        0                           1 
Acute renal failure                                   2(4%)                   3(4%)                0.65(NS) 
HELLP syndrome                                    2(4%)                   0                        0.09(NS) 
 
Birth: 
Caesarian section                                   13(24%)                25(36 )                0.10(NS) 
Induced labour                                       20(37%)                   0                       0.001(S) 
 
Foetal outcome 
Low birth weight                                 28(52%)                   27(39%)                0.11(NS) 
Pre-term delivery                                 29(54%)                   34(49)                   0.18(NS) 
Still birth                                              12 (22%)                    7(10)                   0.04(S) 
Neonatal death                                         0                            1                             
________________________________________________________________________ 
 















Symptoms reported by the patients both at PMH and LCH. 
 
Symptom                                                        PMH (n=54)                           LCH(n=70) 
________________________________________________________________________ 
 
Headache                                                        15(28%)                                           28(40%) 
Dizziness                                                         9(17%)                                              7(10%) 
Epigastric pain                                                  7(13%)                                         18(26%) 
Visual disturbance                                             1(2%)                                             3(4%) 
Nausea                                                               2(4%)                                             1(1.4%) 
Vomiting                                                            2(4%)                                             4(6%) 



































Perinatal outcome for patients with pre-eclampsia and eclampsia at PMH and LCH. 
 
Mild pre-eclampsia Severe pre-eclampsia Eclampsia 
 
 
PMH(N=34)  LCH(N=29) PMH(N=19) LCH(=17) PMH(N=1) LCH(N=24) 
Caesarian 
section 
10(29%) 8(28%) 3(15%) 4(23%) 0 15(62%) 
Low birth 
weight 
14(41%) 2(7%) 13(65%) 10(59%) 1 15(62%) 
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COMPILATION SHEET:  
 
IDENTIFICATION NUMBER AND INITIALS: ………….. 
REFERRED                 1) No         2) Yes      
If yes, referred from ……………………………. 
DEMOGRAPHIC FEATURES (circle as appropriate) 
1. Age (years) …………..   
2. Education level……….  1) none        2) primary   3) secondary                4) tertiary 
3. Marital status …………  1) Married    2) Single   3) Separated/divorced   4) Widow 
4. Gravidity………………  
5. Parity …………………   
6. How many children/pregnancies are: 1) live born? ………… 2) still-born? …………  
3) abortion?………….   4) living today ……………. 
PAST MEDICAL HISTORY: 
1. Chronic hypertension…………..  1)no   2) yes 
2. Pregnancy induced hypertension   1) no    2)yes 
3. Diabetes mellitus ………………  1)no    2) yes 
4. Other (specify)    ............................................ 
PRENATAL CARE ATTENDANCE
1. Booked …………    1) no            2)yes 
2. Gestation age at booking………………… 
3. Number of routine prenatal care visits…………….                 
4. Number of non-routine prenatal care visits……….. 
5. BP at booking ………………………………… 
6. Weight at booking ……………………………. 
7. At what gestation age did the blood pressure increase? ……………… 
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 CLINICAL FEATURES ON ADMISSION (circle as appropriate) : 
1. Headache   ………………….i) no            2)yes          3) Not recorded 
2. Dizziness……………………1) no            2) yes       3) Not recorded 
3. Epigastric pain……………   1) no            2)yes        3) Not recorded 
4. Visual disturbance………… 1) no            2) yes        3) Not recorded 
5. Nausea……………………   1) no            2) yes         3) Not recorded 
6. Vomiting………………….  1) no            2) yes         3) Not recorded 
7. Convulsions………………. 1) no              2) yes           3) Not recorded 
8. Blood pressure: ………………………………… 
9. Oedema…………………..  1) None   2) Mild     3) Moderate  4) Generalized 
10. Height (Metres)…………………………….. 
11. Weight (Kilograms)………………………. 
INVESTIGATIONS:  
1. Haemoglobin   1) lowest Hb …………….   2) highest Hb …………..        
2. Platelet count………………………………………………………….. 
3. Liver function  ………………………     1) Normal    2) Deranged.    
4. Kidney function tests…………………..  1) Normal    2) Deranged      
5. Urea =………….,   
6.  Creatinine …………… 
7. Twenty-four hour urine protein ………………………………… 
8. Dipstick urinalysis………………………. 1) 1) +    2) 2+     3) 3+ 
ANTENATAL MANAGEMENT: 
1. Number of admissions in this pregnancy…………………… 
2. Drugs given during pregnancy 
i. Methyldopa………..           1) no        2 ) yes    
ii. Nifedipine …………          1) no      2) yes    
iii. Hydrallazine………            1) no     2) yes   
iv. Magnesium sulphate               1) no    2) No    
v. Diazepam……………              1) no    b)yes    
vi. Other (Specify)……………………….. 
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 DELIVERY/ TERMINATION OF PREGNANCY : 
1. Gestation……………………… 
2. Blood pressure………………… 
3. Proteinuria …………………………   1) 1+    2)2+    3)3+ 
4. Mode of delivery    1) SVD   2) Induced   3) Vacuum extraction   4) Caesarean section  
4) Other  (specify) ……………………………………… 
MATERNAL COMPLICATIONS (circle): 
 
1. Eclampsia                             1) no        2) yes        3) if yes, 
comments………………………. 
2. Abruptio placentae               1) no        2)yes        3) if yes, 
comments……………………….. 
3. HELLP syndrome…             1) no        2) yes        3) if yes, comments 
……………………… 
4. DIC                                        1) no        2) yes        3) if yes, comments 
…………………… 
5. Acute renal failure …1) no       2) yes      3) if yes, comments 
…………………………… 
6. Pulmonary oedema…1) no        2) yes      3) if yes, comments ………………………… 
7. cerebral pathology …1) no         2) yes      3) if yes, comments 
…………………………  
8. Maternal death ……  1) no         2) yes      3) if yes, comments 
………………………… 
 
PERINATAL OUTCOME  
1. Birth weight ……………………… 
2. Sex     1) male    2) female 
3. Apgar score       1)  at 0 min………………….   2) at 5 min. .………  3) at 10 min. 
........ 
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4. Out come of delivery ……………      1) Live            2) Macerated still birth  c) fresh 
still birth 
5. Neonatal death…………………..      1)no              2) yes 
 
PUPERAL PERIOD 
1. Placenta weight………………………………………………….. 
2. Estimated blood loss……………………………………………. 
3. Duration of hospital stay after delivery………………………… 
4. Blood pressure at discharge…………………………………….. 
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RE: APPLICATION FOR PERMISSION TO CARRY OUT RESEACH: 
 
I am a student at University of Oslo Norway. I am doing a research entitled: Hypertensive 
disorders of pregnancy, complications and obstetric outcome at Princess Marina Hospital. 
While doing data collection I found out that most of hypertensive mothers were referrals 
from city council clinics. I would therefore like to find out the number of deliveries 
conducted in Gaborone city council maternity clinics from December 2002 to April 2003. 
I would like to determine the prevalence of hypertensive disorders of pregnancy in 
Gaborone. 
Find attached copies of clearances of my proposal by ethical committee of Norway, 
Princess Marina Ethical review board and office of the president. Attached also is a copy 
of my research proposal.  
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